More News

18 Apr 2017 Ionis Enters into Collaboration with Ribo to Advance RNA-Targeted Therapeutics in China
18 Apr 2017 HitGen and Pfizer Enter Research Collaboration and License Agreement to Build and Screen Novel DNA-Encoded Libraries
18 Apr 2017 VALNEVA Announces Signing of a New EB66® Commercial License with Bavarian Nordic
18 Apr 2017 Novartis expands development programs for NASH through clinical collaboration with Allergan
17 Apr 2017 CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with StrideBio
14 Apr 2017 Bristol-Myers Squibb Enters into Separate Agreements with Biogen and Roche to License Anti-eTau and Anti-Myostatin Compounds, Respectively
11 Apr 2017 LDC and SOTIO Enter License and Collaboration Agreement for First-in-class Cancer Metabolism Program
11 Apr 2017 Takeda Enters into Strategic Collaboration with NuBiyota for Microbiome Therapeutics
10 Apr 2017 Ferring Announces Exclusive Agreement with Alrise Biosystems for the Development of an Injectable, Controlled-Release Peptide
07 Apr 2017 Biotest AG and Creat enter into Business Combination Agreement
07 Apr 2017 PeptiDream Announces Discovery Collaboration Agreement With Janssen
06 Apr 2017 Immune-Onc Therapeutics, Inc. Announces Partnership with University of Texas to Develop Novel Cancer Immunotherapy
06 Apr 2017 Novartis to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications
05 Apr 2017 Finch Therapeutics and Takeda Announce Global Collaboration to Develop Microbiome Therapeutics in Inflammatory Bowel Disease (IBD)
04 Apr 2017 Sigmoid Pharma Limited Announces a Strategic Collaboration with Dr. Falk Pharma GmBH
04 Apr 2017 UCB and Q-State Biosciences Form Research Collaboration to Develop Novel Therapeutics for Genetic Subtypes of Epilepsy
03 Apr 2017 CCAB Signs Collaboration and License Agreement With Pionyr Immunotherapeutics Inc. to Discover Antibody Drug Development Candidates
03 Apr 2017 Cydan Development Announces the Acquisition of Its First Rare Disease Spin-out, Vtesse, Inc. by Sucampo Pharmaceuticals, Inc.
03 Apr 2017 Astellas to Acquire Ogeda SA
01 Apr 2017 Espero Pharmaceuticals and Armetheon to Merge and Create a Premier Cardiovascular Focused Biopharmaceutical Company
01 Apr 2017 The Center for iPS Cell Research and Application at Kyoto University (CiRA), Takeda and RIKEN Enter a New Collaboration Using iPS Cell Research
31 Mar 2017 Calypso Biotech Licenses CALY-001 Best-In-Class Anti-MMP-9 Antibody to EA Pharma
30 Mar 2017 Visterra Awarded CARB-X Contract to Advance Development of VIS705
30 Mar 2017 Bristol-Myers Squibb Enters Collaboration to Leverage Foundation Medicine’s Molecular Information Platform to Identify Predictive Biomarkers Across Multiple Tumor Types and Immunotherapy Agents
30 Mar 2017 Hanmi/Beijing Hanmi and Innovent Enter into a Global Strategic Partnership to Co-develop a Novel Immuno-oncology Bispecific Antibody

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing